Sep. 19, 2018
Richard Marmaro
See more on Richard MarmaroSkadden, Arps, Slate, Meagher & Flom LLP and Affiliates
The end could be in sight in the long slog of trial and retrial for Marmaro client James Mazzo, a corporate executive accused by the Securities and Exchange Commission and the U.S. Department of Justice of giving material nonpublic information regarding Advanced Medical Optics’ 2009 acquisition by Abbott Laboratories for $2.8 billion. Mazzo is Advanced Medical Optics’ former CEO.
Marmaro said a scheduled third trial in the case “has...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In